|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1994-7-1
|
|
pubmed:abstractText |
We sought to determine the incidence of neutropenic fever associated with the use of standard-dose combination chemotherapy for small-cell lung cancer (SCLC) and to use these data as a template to analyze the costs and benefits of the routine use of granulocyte colony-stimulating factor (G-CSF).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1245-50
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7515413-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7515413-Carcinoma, Small Cell,
pubmed-meshheading:7515413-Drug Costs,
pubmed-meshheading:7515413-Female,
pubmed-meshheading:7515413-Fever,
pubmed-meshheading:7515413-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:7515413-Hospital Charges,
pubmed-meshheading:7515413-Humans,
pubmed-meshheading:7515413-Lung Neoplasms,
pubmed-meshheading:7515413-Male,
pubmed-meshheading:7515413-Middle Aged,
pubmed-meshheading:7515413-Neutropenia,
pubmed-meshheading:7515413-Retrospective Studies
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor.
|
|
pubmed:affiliation |
Department of Medicine, Indiana University School of Medicine, Indianapolis.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
